Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: A Trial on the Treatment of Bronchial Asthma With Budesonide Formoterol Combined With Immune Modulators (Staphylococcus and Neisseria Tablets) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating budesonide/formoterol in combination with immune-modulating tablets (Staphylococcus and Neisseria) for asthma, currently not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol (budesonide/formoterol)
  • Staphylococcus and Neisseria tablets

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Bronchial Asthma | Phase 3 | Status: NOT_YET_RECRUITING